Literature DB >> 32479793

Targeting MET amplification in EGFR-mutant non-small-cell lung cancer.

Rafael Rosell1, Imane Chaib2, Mariacarmela Santarpia3.   

Abstract

Entities:  

Year:  2020        PMID： 32479793     DOI： 10.1016/S2213-2600(20)30171-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  8 in total

Review 1.  Small molecule inhibitors targeting the cancers.

Authors:  Gui-Hong Liu; Tao Chen; Xin Zhang; Xue-Lei Ma; Hua-Shan Shi
Journal:  MedComm (2020)       Date:  2022-10-13

Review 2.  A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations.

Authors:  Mariacarmela Santarpia; Marco Massafra; Vittorio Gebbia; Antonio D'Aquino; Claudia Garipoli; Giuseppe Altavilla; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2021-03

Review 3.  EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?

Authors:  Mario Cioce; Vito Michele Fazio
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

4.  Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.

Authors:  Miao Wang; Qiuji Wu; Jun Zhang; Guizhen Qin; Tian Yang; Yixin Liu; Xulong Wang; Boyu Zhang; Yongchang Wei
Journal:  Cancer Med       Date:  2020-12-15       Impact factor: 4.452

5.  High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.

Authors:  Paul Takam Kamga; Aurélie Swalduz; Adrien Costantini; Catherine Julié; Jean-François Emile; Maurice Pérol; Virginie Avrillon; Sandra Ortiz-Cuaran; Pierre de Saintigny; Etienne Giroux Leprieur
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

6.  MET Amplification and Efficacy of Nivolumab in Patients With NSCLC.

Authors:  Katsuhiro Yoshimura; Yusuke Inoue; Naoki Inui; Masato Karayama; Hideki Yasui; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Haruhiko Sugimura; Takafumi Suda
Journal:  JTO Clin Res Rep       Date:  2021-10-08

7.  Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance.

Authors:  Shuangze Han; Xiaoying Li; Yu Gan; Wei Li
Journal:  Biomed Res Int       Date:  2022-03-10       Impact factor: 3.411

8.  Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Xin Yang; Rui Chen; Yan Chen; You Zhou; Chen Wu; Qing Li; Jun Wu; Wen-Wei Hu; Wei-Qing Zhao; Wei Wei; Jun-Tao Shi; Mei Ji
Journal:  Cancer Sci       Date:  2022-02-22       Impact factor: 6.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.